Tóm tắt
Đặc điểm lân sàng và cận lâm sàng bệnh nhân từ 45 tuổi trở lên bị nhồi máu cơ tim cấp kèm đái tháo đường type 2
Trang chủ
NGHIÊN CỨU LÂM SÀNG
Số phát hành:
Đặc điểm lân sàng và cận lâm sàng bệnh nhân từ 45 tuổi trở lên bị nhồi máu cơ tim cấp kèm đái tháo đường type 2
Huỳnh Kim Phượng: Bệnh viện Chợ Rẫy;
Trương Thành Viễn: Trường Đại học Y khoa Phạm Ngọc Thạch;
Xuất bản: tháng 5 1, 2016
Views: 1
Tài liệu tham khảo
1.
1. Phạm Nguyễn Vinh (2008), Bệnh học Tim mạch, Nhà xuất bản Y học.
2.
2. Trẩn Thị Huỳnh Nga, Hổ Thượng Dũng (2005), “Đặc điểm hình thái tổn thương mạch vành trên bệnh nhân đái tháo đường tip 2" Tạp chí Yhọc TP. Hồ chíMinh, Tạp 15 (2011), phụ bản của Số 1 trang 264- 270.
3.
3. Phạm Mạnh Hùng, Lé Thị Yến, Nguyễn Lân Hiếu (2003), “Đặc điểm tổn thương động mạch vành trên chụp mạch ở bệnh nhân đái tháo đường”. Tạp chí Tim mạch học Việt Nam số 34; trang 18-23.
4.
4. Ngô Hàng Vinh, Phạm Nguyễn Vinh, Phạm Hoà Bình, Nguyễn Ngọc Tú (2011) “Khảo sát các yếu tố nguy cơ tim mạch, tổn thương động mạch vành ở bệnh nhân có tuổi bị nhổi máu cơ tim cấp, có hoặc không có đái tháo đường” Tạp chí Y học TP. Hổ chí Minh, tập 15, phụ bản số 1-2011, trang 200-206.
5.
5. Trương Quang Bình, Đặng Vạn Phước (2006), Bệnh động mạch vành trong thực hành lâm sàng, Nhà xuất bản Y học, p. 1-12.
6.
6. Phạm Nguyễn Vinh, Nguyễn Lân Việt, Trương Quang Binh, (2011) “Nghiên Cứu Quan Sát Điểu Trị Bệnh Nhân Nhập Viện Do Hội Chứng Động Mạch Vành Cấp (MEDI- ACS study)”, Tạp chí Tim mạch học Việt Nam, số 58 tháng 3 năm 2011, trang 12-24.
7.
Tiếng Anh
8.
7. Grundy, S.M., et al (1999). “Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association". Circulation, 100(10), pp. 1134-46.
9.
8. Canto, J.G., et al (2000). “Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain". JAMA, 2000.283(24), pp. 3223-9.
10.
9. Casella G, Savonitto s, Chiarella F, et al (2005) “Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study”. Ital Heart J. 2005 May;6(5):374-83.
11.
10. Michelle c. Odden. “The Impact of the Aging Population on Coronary Heart Disease in the U.S”. Am JMed. 2011 Sep; 124(9): 827-833.e5.
12.
11. Thomas A. Gaziano (2010).“Growing Epidemic of Coronary Heart Disease in Low- and Middle- Income Countries.” CurrProbl Cardiol. 2010 Feb; 35(2): 72-115.
13.
12. Becker A, Bos G, de Vegt F, et al (2003). “Cardiovascular events in type 2 diabetes:comparison with nondiabetic individuals without and with prior cardiovascular disease 10-year follow-up of the Hoorn Study”. Eur Heart J, 24(15), pp.1406-1413.
14.
13. Gruppetta M, Calleja N, Fava s (2010). “Long-Term Survival After Acute Myocardial Infarction and Relation to Type 2 Diabetes and Other Risk Factors”. Clin Cardiol, 33(7), pp.424-429.
15.
14. Leahy JL1 (2005). “Pathogenesis of type 2 diabetes mellitus”. Arch Med Res, 36(3), pp.197-209.
16.
15. Arauz-Pacheco c, Parrott MA, Raskin p (2003). ’’Treatment of Hypertension in Adults With Diabetes”. Diabetes Care. 26 Suppl LS80-2.
17.
16. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. 7 Hypertens. 1993 Mar;ll(3), pp.309-317.
18.
17. Jonas Ml, Reicher-Reiss H, Boyko V, et al (2003). “Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension”. J Hum Hypertens. 17(10), pp.665-670.
19.
18. Epstein M, Sowers JR (1992). “Diabetes mellitus and hypertension”. Hypertension, 19, pp. 403-418.
20.
19. Grossman E, Messereli FH (1996). “Diabetic and hypertensive hear disease”. Ann Intern Med, 125,pp. 304-310.
21.
20. Femandez-Britto JE et al (1991). “Atherosclerosis in diabetes and hypertension. A comparative morphometric study of their progression using an atherometric system”. Zenừalbl Pathol, 137, pp. 487-491.
22.
21. Arora GD, Reeves wc, Movahed A (1994). “Alteration of coronary perfusion reserve in hypertensive patients with diabetes”. 7 Hum Hypertens,8, pp. 51-57.
23.
22. Dixit AK, Dey R, Suresh A et al (2014).”1he prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital”.7Diabetes MetabDisord, 22, pp. 13:58.
24.
23. Kannel WB (1985). “Lipids, diabetes, and coronary heart disease: insightsfrom the Framingham Study”. Am Heart 7,110, pp.l 100-7.
25.
24. Jacobs MJ, Kleisli T, Pio JR, et al (2005). “Prevalence and control of dyslipidemia among persons with diabetes in the United States”. Diabetes Res Clin Pract,70, pp.263-2699.
26.
25. U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Cflre.l997;20:1683-87.
27.
26. Parish s, Offer A, Clarke R, et al (2012). “Heart Protection Study Collaborative Group. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF heart protection study”. Circulation, 125, pp.2469-2478.
28.
27. Chehade JM, GladyszM, Mooradian AD (2013). “Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management”. Drugs, 73(4), pp. 327-339.
29.
28. Arshag D Mooradian (2009). “Dyslipidemia in type 2 diabetes mellitus”. Nature Reviews Endocrinology, 5, pp. 150-159.
30.
29. Jonathan Valabhji, Robert s Elkeles (2003). Dyslipidemia in Type 2 Diabetes: Epidemiology and Biochemistry. British Journal of Diabetes and Vascular Disease, 3(3), pp.121-129.
31.
30. Karpe F, Dickmann JR (2011). Fatty acids, obesity, and insulin resistance: time for a réévaluation. Diabetes. 2011 Oct;60(l0):2441-9.
32.
31. Ridderstrảle M, Gudbjornsdottir s, Eliasson B, et al (2006). “Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. JIntern Med, 259(3), pp. 314-322.
33.
32. Scognamiglio R, Negut c, Ramondo A, Tiengo A, Avogaro A (2006). “Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus ". J Am Coll Cardiol. 47(1), pp.65-71.
34.
33. Khafaji HA, Suwaidi JM (2014). “Atypical presentation of acute and chronic coronary artery disease in diabetics”. World J Cardiol, 6(8), pp. 802 813.
35.
34. Culic V, Eterovic D, Miric D, SilicN (2002). “Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors”. Am Heart 7,144, pp.1012-1017.
36.
35. Seon Young Hwang,1 Eun Hee Park,l Eun Sook Shin, et al (2009). “Comparison of Factors Associated with Atypical Symptoms in Younger and older Patients with Acute Coronary Syndromes”. 7 Korean Med Sci, 24(5), pp. 789-794.
37.
36. Vaccarino V, Parsons L, Every NR, et al (1999). “Sex-based differences inearly mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants”. N Engl 7 Med, 341(4), pp. 217-25.
38.
37. Brieger D, Eagle KA, Goodman SG, et al (2004). “Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events”. Chest, 126(2), pp. 461-9.
39.
38. Coronado BE, Pope JH, Griffith JL, et al (2004). “Clinical features, triage, and outcome of patients presenting to the ED with suspected acute coronary syndromes but without pain: a multicenter study”. Am 7 EmergMed, 22, pp. 568-574.
40.
39. Granger CB, Califf RM, Young s, et al (1993). “Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group”. 7 Am Coll Cardiol, 21(4), pp.920-925.
41.
40. Morgan KP, Kapur A and Beatt KJ (2004). “Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention”. Heart, 90(7), pp.732-738.
42.
41. LindvallBl, BrorssonB, HerlitzJ, etal ( 1999). “Comparison ofdiabeticand non-diabetic patients referred for coronary angiography”. Int7 Cardiol, 70(1 ),pp. 33-42.
43.
42. Hanssen M, Cottin Y, Khalife K, et al (2012).” French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010.” Heart. 2012 May;98(9):699-705.
44.
43. Adler AI, Stratton IM, Neil HA, et al (2000). “Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.“.BM/,2000 Aug 12; 321 (7258): 412-9.
45.
44. Ann D Colosia, Roberto Palencia, et al (2013). “Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013; 6: 327-338.
46.
45. Iharkar S, Satyavani K, Viswanathan V. Cost of medical care among type 2 diabetic patients with a co-morbid condition—hypertension in India (2009). Diabetes Res Clin Pract. 2009 Feb; 83(2):263-7.
47.
46. Dixit AK, Dey R, Suresh A,et la (2014). “The prevalence of dyslipidemia in patients with diabetes mellitus of ayurvéda Hospital.” / Diabetes Metab Disord. 2014 May 22; 13:58.
48.
\47. Mooradian AD (2009). Dyshpidemia in type 2 diabetes melbtus. Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3): 150-9.
49.
48. Golay A, Ybarra J, et al (2005).” Link between obesity and type 2 diabetes.” Best Pract Res Clin Endocrinol Metab. 2005 Dec; 19(4) :649-63.
50.
49. Tong-guo Wu, Lexin Wang (2002). “Angiographic characteristics of the coronary artery in patients with type 2 diabetes”.Ejcp Clin Cardiol. 2002 Winter; 7(4): 199-200.
51.
50. Natali A, Vichi S, Landi P, et al (2000). “Coronary atherosclerosis in Type II diabetes: angiographic findings and dinical outcome.” Diabetologia. 2000 May;43(5):632-41.
52.
51. Laura C. Plantinga, Deidra C. Crews, et al (2010). “Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes.” CbnJ Am Soc Nephrol. 2010 Apr; 5(4): 673-682.
53.
52. Lou Arnal LM, Campos Gutierrez B, et al (2010). “Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care.” Nefrologia. 2010;30(5):552-6.